Lung function declines naturally over the course of the human lifespan. However, this decline is steeper in individuals who experience moderate or high weight gain. This was the conclusion of a new study led by the Barcelona ...
Feb 25, 2020
0
5
Researchers have identified a distinct collection of bacteria found in the gut that may contribute to and predict the development of pulmonary arterial hypertension (PAH), according to new research published today in the ...
Feb 24, 2020
0
200
A new Cleveland Clinic study has uncovered a genetic anomaly associated with poor response to a common asthma treatment. The findings, published in Proceedings of the National Academy of Sciences, showed that asthmatic patients ...
Jan 13, 2020
0
55
Researchers at National Jewish Health and around the world report today that a three-drug combination of medications can improve lung function, reduce exacerbations and improve quality of life for people with cystic fibrosis ...
Dec 12, 2019
0
25
University of Maryland School of Medicine (UMSOM) researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by using an inhaled form of the immunosuppression ...
Nov 14, 2019
0
50
Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United ...
Nov 12, 2019
0
10
People who smoke fewer than five cigarettes a day cause long-term damage to their lungs, according to a new study led by researchers at Columbia University Vagelos College of Physicians and Surgeons.
Oct 9, 2019
0
187
A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin may lessen the adverse effects of air pollution exposure on lung function. The team of researchers from the Columbia ...
Oct 3, 2019
0
236
Women with polycystic ovary syndrome (PCOS) are more likely to develop poor respiratory health based on lung function tests, according to research presented at the European Respiratory Society International Congress.
Oct 2, 2019
0
2
Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. The findings, published in the New England ...
Sep 30, 2019
0
34
